J Knee Surg 2020; 33(02): 100-105
DOI: 10.1055/s-0039-1695742
Special Focus Section
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Dual Antibiotic Prophylaxis in Total Knee Arthroplasty: Where Do We Stand?

Jesus M. Villa
1   Levitetz Department of Orthopaedic Surgery and Rehabilitation, Cleveland Clinic Florida, Weston, Florida
,
Tejbir S. Pannu
1   Levitetz Department of Orthopaedic Surgery and Rehabilitation, Cleveland Clinic Florida, Weston, Florida
,
Aldo M. Riesgo
1   Levitetz Department of Orthopaedic Surgery and Rehabilitation, Cleveland Clinic Florida, Weston, Florida
,
Preetesh D. Patel
1   Levitetz Department of Orthopaedic Surgery and Rehabilitation, Cleveland Clinic Florida, Weston, Florida
,
Michael A. Mont
2   Department of Orthopedic Surgery, Lenox Hill Hospital, New York, New York
,
Carlos A. Higuera-Rueda
1   Levitetz Department of Orthopaedic Surgery and Rehabilitation, Cleveland Clinic Florida, Weston, Florida
› Author Affiliations
Further Information

Publication History

20 March 2019

22 July 2019

Publication Date:
30 August 2019 (online)

Abstract

The risk of surgical site infection in primary total knee arthroplasty (TKA) has been reduced with the use of prophylactic antibiotics. First or second generation cephalosporins are still recommended as the primary prophylactic choice, but with the rise in the incidence of methicillin-resistant Staphylococcus aureus (MRSA) infections, evidence has emerged in favor of using dual antibiotics including vancomycin. However, it is unclear whether these combinations of antibiotic regimens further reduce postoperative infection rates. As a result, the objective of this review is to summarize the current literature concerning the use of dual prophylactic antibiotics in TKA. The most common dual prophylactic antibiotic combination is cefazolin (C) and vancomycin (V). In general, when comparing the effectiveness of single versus dual antibiotics, conflicting results have been reported. Three studies demonstrated no substantial decrease in overall postoperative infection rates with the use of dual antibiotics when compared with cefazolin alone. One found a significant decrease only in MRSA infection rates when using cefazolin and vancomycin (CV) (0.8% C alone vs. 0.08% CV, p < 0.05). Another investigation evaluated revision TKA patients who had combined cefazolin and vancomycin prophylaxis and showed a significant decline in both overall infection (7.89% [C] vs. 3.13% [CV]) and MRSA infection rates (4.21% [C] vs. 0.89% [CV]; p < 0.05). Concerning the safety profile of dual antibiotics, particular precautions must be adopted with the use of vancomycin because of the risk of acute kidney injury. Instead of vancomycin, an alternate less nephrotoxic antibiotic option might be teicoplanin. Unfortunately, this latter agent is only available outside of the United States. In conclusion, the value of dual antibiotic prophylaxis for the prevention of periprosthetic knee infections remains unclear primarily because all comparative studies performed between dual and single antibiotics have been of low evidence with retrospective designs. Larger multicenter randomized controlled trials are warranted.

 
  • References

  • 1 Zmistowski B, Della Valle C, Bauer TW. , et al. Diagnosis of periprosthetic joint infection. J Arthroplasty 2014; 29 (2, Suppl): 77-83
  • 2 AlBuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br 2008; 90 (07) 915-919
  • 3 Hansen E, Belden K, Silibovsky R. , et al. Perioperative antibiotics. J Arthroplasty 2014; 29 (2, Suppl): 29-48
  • 4 Bratzler DW, Houck PM. ; Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005; 189 (04) 395-404
  • 5 Sewick A, Makani A, Wu C, O'Donnell J, Baldwin KD, Lee GC. Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty?. Clin Orthop Relat Res 2012; 470 (10) 2702-2707
  • 6 Liu C, Kakis A, Nichols A, Ries MD, Vail TP, Bozic KJ. Targeted use of vancomycin as perioperative prophylaxis reduces periprosthetic joint infection in revision TKA. Clin Orthop Relat Res 2014; 472 (01) 227-231
  • 7 Parvizi J, Gehrke T, Chen AF. Proceedings of the international consensus on periprosthetic joint infection. Bone Joint J 2013; 95 B (11) 1450-1452
  • 8 Aboltins CA, Berdal JE, Casas F. , et al. Hip and knee section, prevention, antimicrobials (systemic): proceedings of international consensus on orthopedic infections. J Arthroplasty 2019; 34 (2S): S279-S288
  • 9 Burger JR, Hansen BJ, Leary EV, Aggarwal A, Keeney JA. Dual-agent antibiotic prophylaxis using a single preoperative vancomycin dose effectively reduces prosthetic joint infection rates with minimal renal toxicity risk. J Arthroplasty 2018; 33 (7S): S213-S218
  • 10 Branch-Elliman W, Ripollone JE, O'Brien WJ. , et al. Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: a national propensity-score-adjusted retrospective cohort study. PLoS Med 2017; 14 (07) e1002340
  • 11 Cohen-Rosenblum A, Crutcher M, Gui J, Novicoff W, Nelson S, Browne J. Dual antibiotic therapy with vancomycin and cefazolin for surgical prophylaxis in total knee arthroplasty. Reconstr Rev 2018; 8 (02) 29-33 . doi:10.15438/rr.8.2.212
  • 12 Page CP, Bohnen JMA, Fletcher JR, McManus AT, Solomkin JS, Wittmann DH. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg 1993; 128 (01) 79-88
  • 13 Holmes RL, Jorgensen JH. Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006. Antimicrob Agents Chemother 2008; 52 (02) 757-760
  • 14 Neu HC. Cephalosporin antibiotics as applied in surgery of bones and joints. Clin Orthop Relat Res 1984; (190) 50-64
  • 15 Holm A, Mosbech H. Challenge test results in patients with suspected penicillin allergy, but no specific iGE. Allergy Asthma Immunol Res 2011; 3 (02) 118-122
  • 16 Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of cephalosporins in penicillin-allergic patients: a literature review. J Emerg Med 2012; 42 (05) 612-620
  • 17 Borch JE, Andersen KE, Bindslev-Jensen C. The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population. Basic Clin Pharmacol Toxicol 2006; 98 (04) 357-362
  • 18 Annè S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995; 74 (02) 167-170
  • 19 Vaisman A, McCready J, Hicks S, Powis J. Optimizing preoperative prophylaxis in patients with reported β-lactam allergy: a novel extension of antimicrobial stewardship. J Antimicrob Chemother 2017; 72 (09) 2657-2660
  • 20 Crawford T, Rodvold KA, Solomkin JS. Vancomycin for surgical prophylaxis?. Clin Infect Dis 2012; 54 (10) 1474-1479
  • 21 Bratzler DW, Dellinger EP, Olsen KM. , et al; American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epidemiology of America. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70 (03) 195-283
  • 22 Chambers HF. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis 2001; 7 (02) 178-182
  • 23 Graziani AL, Lawson LA, Gibson GA, Steinberg MA, MacGregor RR. Vancomycin concentrations in infected and noninfected human bone. Antimicrob Agents Chemother 1988; 32 (09) 1320-1322
  • 24 Kheir MM, Tan TL, Azboy I, Tan DD, Parvizi J. Vancomycin prophylaxis for total joint arthroplasty: incorrectly dosed and has a higher rate of periprosthetic infection than cefazolin. Clin Orthop Relat Res 2017; 475 (07) 1767-1774
  • 25 Ponce B, Raines BT, Reed RD, Vick C, Richman J, Hawn M. Surgical site infection after arthroplasty: comparative effectiveness of prophylactic antibiotics: do surgical care improvement project guidelines need to be updated?. J Bone Joint Surg Am 2014; 96 (12) 970-977
  • 26 Catanzano A, Phillips M, Dubrovskaya Y, Hutzler L, Bosco III J. The standard one gram dose of vancomycin is not adequate prophylaxis for MRSA. Iowa Orthop J 2014; 34: 111-117
  • 27 Lamplot JD, Luther G, Mawdsley EL, Luu HH, Manning D. Modified protocol decreases surgical site infections after total knee arthroplasty. J Knee Surg 2015; 28 (05) 395-403
  • 28 Galandiuk S, Polk Jr HC, Jagelman DG, Fazio VW. Re-emphasis of priorities in surgical antibiotic prophylaxis. Surg Gynecol Obstet 1989; 169 (03) 219-222
  • 29 AAOS. Recommendations for the Use of Intravenous Antibiotic Prophylaxis in Primary Total Joint Arthroplasty. 2004 :1–6.
  • 30 Williams DN, Gustilo RB. The use of preventive antibiotics in orthopaedic surgery. Clin Orthop Relat Res 1984; (190) 83-88
  • 31 Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13 (10) 606-608
  • 32 WHO Surgical Site Infection Prevention Guidelines. (Appendix 13)
  • 33 Parvizi J, Zmistowski B, Berbari EF. , et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 2011; 469 (11) 2992-2994
  • 34 Bamgbola O. Review of vancomycin-induced renal toxicity: an update. Ther Adv Endocrinol Metab 2016; 7 (03) 136-147
  • 35 Courtney PM, Melnic CM, Zimmer Z, Anari J, Lee G-C. Addition of vancomycin to cefazolin prophylaxis is associated with acute kidney injury after primary joint arthroplasty. Clin Orthop Relat Res 2015; 473 (07) 2197-2203
  • 36 Wallace MR, Mascola JR, Oldfield III EC. Red man syndrome: incidence, etiology, and prophylaxis. J Infect Dis 1991; 164 (06) 1180-1185
  • 37 Healy DP, Sahai JV, Fuller SH, Polk RE. Vancomycin-induced histamine release and “red man syndrome”: comparison of 1- and 2-hour infusions. Antimicrob Agents Chemother 1990; 34 (04) 550-554
  • 38 Polk RE, Healy DP, Schwartz LB, Rock DT, Garson ML, Roller K. Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis 1988; 157 (03) 502-507
  • 39 Wazny LD, Daghigh B. Desensitization protocols for vancomycin hypersensitivity. Ann Pharmacother 2001; 35 (11) 1458-1464
  • 40 Tornero E, García-Ramiro S, Martínez-Pastor JC. , et al. Prophylaxis with teicoplanin and cefuroxime reduces the rate of prosthetic joint infection after primary arthroplasty. Antimicrob Agents Chemother 2015; 59 (02) 831-837
  • 41 Bosco JA, Catanzano AJ, Stachel AG, Phillips MS. ; Prince Rainier R Tejada. Expanded gram-negative antimicrobial prophylaxis reduces surgical site infections in hip arthroplasty. J Arthroplasty 2016; 31 (03) 616-621